Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases

Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases

Purpose: Randomized data show a survival benefit of stereotactic ablative body radiation therapy in selected patients with oligometastases (OM). Stereotactic magnetic resonance guided adaptive radiation therapy (SMART) may facilitate the delivery of ablative dose for OM lesions, especially those adj...

Full description

Bibliographic Details
Main Authors: Tugce Kutuk, MD, Robert Herrera, BS, Teuta Z. Mustafayev, MD, Gorkem Gungor, PhD, Gamze Ugurluer, MD, Banu Atalar, MD, Rupesh Kotecha, MD, Matthew D. Hall, MD, MBA, Muni Rubens, MBBS, MPH, PhD, Kathryn E. Mittauer, PhD, Jessika A. Contreras, MD, James McCulloch, DMP, Noah S. Kalman, MD, MBA, Diane Alvarez, MSc, Tino Romaguera, PhD, Alonso N. Gutierrez, PhD, MBA, Jacklyn Garcia, BS, Adeel Kaiser, MD, Minesh P. Mehta, MD, Enis Ozyar, MD, Michael D. Chuong, MD
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422000859

Internet

http://www.sciencedirect.com/science/article/pii/S2452109422000859

Similar Items